[1] Aydiner A,Toker A,Sen F,et al.Association of clinical and pathological variables with survival in thymoma[J].Med Oncol,2012,29(3):2221-2228.
[2] Weksler B,Dhupar R,Parikh V,et al.Thymic carcinoma:a multivariate analysis of factors predictive of survival in 290 patients [J].Ann Thorac Surg,2013,95(1):299-303.
[3] Ahmad U,Yao X,Detterbeck F,et al.Thymic carcinoma outcomes and prognosis:results of an international analysis [J].J Thorac Cardiovasc Surg,2015,149(1):95-100.
[4] Filosso PL,Guerrera F,Rendina AE,et al.Outcome of surgically resected thymic carcinoma:a multicenter experience [J].Lung Cancer,2014,83(2):205-210.
[5] Wright CD,Wain JC,Wong DR,et al.Predictors of recurrence in thymic tumors:importance of invasion,World Health Organization histology,and size [J].J Thorac Cardiovasc Surg,2005,130(5):1413-1421.
[6] Ruffini E.Thymic carcinoma:a cohort study of patients from the European society of thoracic surgeons database [J].J Thorac Oncol,2014,9(4):541-548.
[7] Zhang Z,Cui Y,Jia R,et al.Myasthenia gravis in patients with thymoma affects survival rate following extended thymectomy [J].Oncol Lett,2016,11(6):4177-4182.[8] 钱昆杰,孙清超,李德生,等.胸腺瘤合并重症肌无力患者术后远期疗效及影响因素分析 [J].中国胸心血管外科临床杂志,2016,23(7):698-701.
[9] 汪昉睿,庞烈文,傅剑华,等.合并重症肌无力的胸腺瘤患者术后生存的初步分析——ChART数据库回顾性结果 [J].中国肺癌杂志,2016,19(7):418-424.
[10] 马可,谷志涛,韩泳涛,等.术后化疗胸腺肿瘤中的应用及对其预后的影响[J].中国肺癌杂志,2016,19(7):473-482.
[11] Sandri A,Cusumano G,Lococo F,et al.Long-term results after treatment for recurrent thymoma:a multicenter analysis [J].J Thorac Oncol,2014,9(12):1796-1804. |
2018, Vol. 35 
